Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 28, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced financial results for the third quarter...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 21, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage, specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced the appointment of Thomas H. Bliss, Jr...
Interpace Biosciences (IDXG) +72% after completing an independent investigation into complaints and finds it unsubstantiated.Allscripts Healthcare Solutions (MDRX) +38% on announcing to sell its CarePort Health business to WellSky.VOXX International Corporation (VOXX) ...
Taiwan Liposome (TLC) has enrolled the first subject in the Phase I clinical trial of TLC19 for treatment or prophylaxis of COVID-19. The Phase I randomized study will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses of inhaled TLC19 in 30 healthy volunte...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 14, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that the first subject has been enrolle...
Gainers: AgeX Therapeutics (AGE) +253%.Mexco Energy (MXC) +50%.Eaton Vance (EV) +48%.BIO-key International (BKYI) +42%.Consumer Portfolio Services (CPSS) +41%.Oxbridge Re (OXBR) +38%.Houston American Energy (HUSA) +30%.Alphatec (ATEC) +25%.VOC Energy Trust (VOC) +23%.Jumia Technologies (...
Gainers: AgeX Therapeutics (AGE) +260%. Alphatec (ATEC) +36%. CareDx (CDNA) +19%. Selecta Biosciences (SELB) +16%. Tiziana Life Sciences (TLSA) +13%.Losers: Cytokinetics (CYTK) -44%. Taiwan Liposome (TLC) -18%. IMARA (IMRA) -7%. GenMark Diagnostics (GNMK) -6...
Ocean Power Technologies (OPTT) -13%.ENGlobal (ENG) -11%.Pioneer Power Solutions (PPSI) -12%.Taiwan Liposome (TLC) -10%.Westwater Resources (WWR) -9%.Muscle Maker (GRIL) -9%.ReneSola (SOL) -8%.Phunware (PHUN) -8%.CVD Equipment (CVV) -7%.Sunworks (SUNW) -6%.Gladstone Land (LAND) -6% ...
Gainers: The Peck Company (PECK) +67%.CVD Equipment (CVV) +56%.Sunworks (SUNW) +47%.Ocean Power Technologies (OPTT) +42%.ReneSola (SOL) +35%.Taiwan Liposome (TLC) +29%.Ocular Therapeutix (OCUL) +20%.Broadwind (BWEN) +19%.Chimerix (CMRX) +16%.3D Systems (DDD) +16%.Losers: Electro-Sen...
Gainers: Taiwan Liposome (TLC) +36%. Ocular Therapeutix (OCUL) +21%. LogicBio Therapeutics (LOGC) +11%. American Well (AMWL) +11%. Tiziana Life Sciences (TLSA) +11%.Losers: Enlivex Therapeutics (ENLV) -12%. Aytu BioScience (AYTU) -12%. Xtant Medical (XTNT) -11%. ARCA bioph...
News, Short Squeeze, Breakout and More Instantly...
Taiwan Liposome Company Ltd. Company Name:
TLC Stock Symbol:
NASDAQ Market:
Taiwan Liposome Company Ltd. Website:
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has entered a commercialization agreem...